Cellmid to supply diagnostic antibodies to Fujikura

Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major suppli...

February 11, 2013 | Monday | News
Daiichi Sankyo's Subsidiary Ranbaxy merged with Sun Pharma

Japanese pharma major Daiichi Sankyo Company Limited has announced the completion of the merger process of its subsidiar...

March 26, 2015 | Thursday | News
Progenics initiates Fuji's Phase 2 Trial for prostate cancer drug in Japan

New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...

April 8, 2015 | Wednesday | News
Daiichi Sankyo Espha's TB drugs approved in Japan

Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...

August 25, 2015 | Tuesday | News
Kotaro Yoshida: China, Japan are the new M&A hot spots

Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...

June 12, 2013 | Wednesday | Opinion
CHA Health Systems partners with Otsubo-Kai

Singapore: South Korea-based global healthcare enterprise, CHA Health Systems has inked a pact with Japanese medical cor...

May 12, 2015 | Tuesday | News
BMS, Japan firm collaborate to develop new immunotherapies

Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...

July 30, 2015 | Thursday | News
Takeda, Kyoto University to co-develop stem cell therapies

Singapore: Japanese drugmaker Takeda has inked a 10-year pact with Japan's Kyoto University to co-develop stem cell ther...

April 20, 2015 | Monday | News
WaVe Life Sciences raises $18 mn to develop nucleic acid therapeutics

Japan-US joint venture company WaVe Life Sciences announced that it has closed an $18 million Series A financing led by ...

February 4, 2015 | Wednesday | News
Takeda, Immunogen in a cancer drug deal

Singapore: Immunogen has inked a pact with Japanese drugmaker Takeda pharmaceuticals that gives Takeda exclusive rights ...

March 25, 2015 | Wednesday | News
BSA-CMR Survey: Asian CROs optimistic in a gloomy pharma market

Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...

September 18, 2013 | Wednesday | Analysis
DIA executive director calls it quits

Singapore: Executive director of DIA, Mr Paul Pomerantz is quitting his position effective March 3, 2013, to assume the ...

December 6, 2012 | Thursday | News
Dotmatics appoints Takashi Fukuyama to spearhead new Japanese business

Dotmatics, a UK-based provider of scientific informatics solutions and services, announced its extension of operations t...

April 29, 2015 | Wednesday | News
Germany, Japan researchers reveal neuron behavior

Singapore: An international team of researchers at German Center for Neurodegenerative Diseases (DZNE) and Tokyo Institu...

April 17, 2015 | Friday | Opinion
Additional indication for Otsuka's Samsca in Japan

Singapore: Japan-based drugmaker Otsuka Pharmaceutical's vasopressin V2 receptor antagonist Samsca 7.5mg tablets has bee...

September 18, 2013 | Wednesday | News
Phosphagenics licenses TPM/Oxycodone Patch to an undisclosed Japanese company

Australian biotechnology company, Phosphagenics Limited has expanded its existing license option agreement, with one of ...

May 18, 2016 | Wednesday | News
Takeda has innovative plan to invest in Israel through TVI

Singapore: Japan-based Pharma Takeda has increased its efforts for strategic investments in Israel through its Silicon V...

May 17, 2015 | Sunday | News
Japan's JCR adopts Medidata's Clinical Cloud solution

US-based provider of cloud-based solutions for clinical research in life sciences, Medidata has announced that its cloud...

June 26, 2015 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls